{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:51:55Z","timestamp":1790175115295,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00131","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T04:40:00Z","timestamp":1550810400000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Hereditary Spastic Paraplegia Is a Common Phenotypic Finding in ARG1 Deficiency, P5CS Deficiency and HHH Syndrome: Three Inborn Errors of Metabolism Caused by Alteration of an Interconnected Pathway of Glutamate and Urea Cycle Metabolism"],"prefix":"10.3389","volume":"10","author":[{"given":"Emanuele","family":"Panza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Magini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dionisi Vici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Seri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.expneurol.2003.08.005","article-title":"Advances in the hereditary spastic paraplegias","volume":"184","author":"Fink","year":"2003","journal-title":"Exp Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1055\/s-0034-1386767","article-title":"Hereditary spastic paraplegia: clinical principles and genetic advances","volume":"34","author":"Fink","year":"2014","journal-title":"Semin Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/ejhg.2017.124","article-title":"Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias","volume":"25","author":"Morais","year":"2017","journal-title":"Eur J Hum Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neurol.2017.06.020","article-title":"Motor neuron disease in inherited neurometabolic disorders","volume":"174","author":"De","year":"2018","journal-title":"Rev Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/brain\/awv143","article-title":"Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia","volume":"138","author":"Coutelier","year":"2015","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1093\/brain\/awv247","article-title":"ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism","volume":"139","author":"Panza","year":"2016","journal-title":"Brain"},{"key":"B7","first-page":"131","article-title":"A new inherited metabolic disease: delta1-pyrroline 5-carboxylate synthetase deficiency","volume":"182","author":"Kamoun","year":"1998","journal-title":"Bull Acad Natl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1093\/hmg\/9.19.2853","article-title":"Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase","volume":"9","author":"Baumgartner","year":"2000","journal-title":"Hum Mol Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00431-004-1545-3","article-title":"Delta1-pyrroline-5-carboxylate synthase deficiency: neurodegeneration, cataracts and connective tissue manifestations combined with hyperammonaemia and reduced ornithine, citrulline, arginine and proline","volume":"164","author":"Baumgartner","year":"2005","journal-title":"Eur J Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00726-008-0075-0","article-title":"Human Delta1-pyrroline-5-carboxylate synthase: function and regulation","volume":"35","author":"Hu","year":"2008","journal-title":"Amino Acids"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1093\/brain\/awv248","article-title":"Reply: ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism","volume":"139","author":"Coutelier","year":"2016","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ajhg.2015.08.001","article-title":"Recurrent de novo mutations affecting residue Arg138 of pyrroline-5-carboxylate synthase cause a progeroid form of autosomal-dominant cutis laxa","volume":"97","author":"Fischer-Zirnsak","year":"2015","journal-title":"Am J Hum Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/jhg.2017.18","article-title":"Autosomal dominant cutis laxa with progeroid features due to a novel, de novo mutation in ALDH18A1","volume":"62","author":"Bhola","year":"2017","journal-title":"J Hum Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ymgme.2014.05.003","article-title":"Severe congenital cutis laxa with cardiovascular manifestations due to homozygous deletions in ALDH18A1","volume":"112","author":"Fischer","year":"2014","journal-title":"Mol Genet Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1203\/00006450-198709000-00025","article-title":"Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: low creatine excretion and effect of citrulline, arginine, or ornithine supplement","volume":"22","author":"Dionisi","year":"1987","journal-title":"Pediatr Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1212\/WNL.57.5.911","article-title":"Clinical and molecular findings in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome","volume":"57","author":"Salvi","year":"2001","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0887-8994(01)00335-6","article-title":"A novel mutation, P126R, in a Japanese patient with HHH syndrome","volume":"26","author":"Miyamoto","year":"2002","journal-title":"Pediatr Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-015-0242-9","article-title":"The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome","volume":"10","author":"Martinelli","year":"2015","journal-title":"Orphanet J. Rare Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/dmcn.12488","article-title":"Treatment of arginase deficiency revisited: guanidinoacetate as a therapeutic target and biomarker for therapeutic monitoring","volume":"56","author":"Amayreh","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ymgme.2004.11.004","article-title":"Hyperargininemia due to liver arginase deficiency","volume":"84","author":"Crombez","year":"2005","journal-title":"Mol Genet Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.pediatrneurol.2014.05.029","article-title":"Hyperargininemia: 7-month follow-up under sodium benzoate therapy in an Italian child presenting progressive spastic paraparesis, cognitive decline, and novel mutation in ARG1 gene","volume":"51","author":"Baranello","year":"2014","journal-title":"Pediatr Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1023\/A:1005492819527","article-title":"Adult-onset arginase deficiency","volume":"21","author":"Cowley","year":"1998","journal-title":"J Inherit Metab Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00439-011-1119-1","article-title":"Modeling human neurodegenerative diseases in transgenic systems","volume":"131","author":"Gama","year":"2012","journal-title":"Hum Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1939-1676.1997.tb00101.x","article-title":"Persistent hyperammonemia in two related Morgan weanlings","volume":"11","author":"McCornico","year":"1997","journal-title":"J Vet Intern Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1128\/MCB.22.13.4491-4498.2002","article-title":"Mouse model for human arginase deficiency","volume":"22","author":"Iyer","year":"2002","journal-title":"Mol Cell Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ymgme.2006.04.007","article-title":"Ornithine deficiency in the arginase double knockout mouse","volume":"89","author":"Deignan","year":"2006","journal-title":"Mol Genet Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ymgme.2007.09.016","article-title":"Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia","volume":"93","author":"Deignan","year":"2008","journal-title":"Mol Genet Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10545-011-9411-8","article-title":"Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine","volume":"35","author":"Martinelli","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1172-7-32","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders","volume":"7","author":"H\u00e4berle","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pediatrneurol.2010.11.003","article-title":"Argininemia presenting with progressive spastic diplegia","volume":"44","author":"Lee","year":"2011","journal-title":"Pediatr Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.lfs.2013.06.013","article-title":"Disturbance of redox homeostasis by ornithine and homocitrulline in rat cerebellum: a possible mechanism of cerebellar dysfunction in HHH syndrome","volume":"93","author":"Zanatta","year":"2013","journal-title":"Life Sci"},{"key":"B32","first-page":"875","article-title":"The hyperornithinemias","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Valle","year":"2001"},{"key":"B33","first-page":"797","article-title":"Ornithine in vivo administration disrupts redox homeostasis and decreases synaptic Na(+), K (+)-ATPase activity in cerebellum of adolescent rats: implications for the pathogenesis of hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome","volume-title":"Cell Mol Neurobiol","author":"Zanatta","year":"2015"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ng.413","article-title":"Mutations in PYCR1 cause cutis laxa with progeroid features","volume":"41","author":"Reversade","year":"2009","journal-title":"Nat Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00726-011-0853-y","article-title":"The metabolic burden of creatine synthesis","volume":"40","author":"Brosnan","year":"2011","journal-title":"Amino Acids"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00726-011-0852-z","article-title":"Creatine deficiency syndromes and the importance of creatine synthesis in the brain","volume":"40","author":"Braissant","year":"2011","journal-title":"J Amino Acids"},{"key":"B37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10545-012-9494-x","article-title":"Creatine metabolism in urea cycle defects","volume":"35","author":"Boenzi","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.ymgme.2010.02.020","article-title":"Creatine metabolism and the urea cycle","volume":"100","author":"Brosnan","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/15548627.2018.1444312","article-title":"Targeting autophagy for therapy of hyperammonemia","volume":"14","author":"Soria","year":"2018","journal-title":"Autophagy"},{"key":"B40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1055\/s-0037-1608652","article-title":"Congenital disorders of autophagy: what a pediatric neurologist should know","volume":"49","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Neuropediatrics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/nyas.12426","article-title":"AP1S1 defect causing MEDNIK syndrome: a new adaptinopathy associated with defective copper metabolism","volume":"1314","author":"Martinelli","year":"2014","journal-title":"Ann NY Acad Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"E10697","DOI":"10.1073\/pnas.1717327114","article-title":"AP-4 mediates export of ATG9A from the trans-Golgi network to promote autophagosome formation","volume":"114","author":"Mattera","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B43","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jnc.13708","article-title":"Post-translational protein arginylation in the normal nervous system and in neurodegeneration","volume":"138","author":"Galiano","year":"2016","journal-title":"J Neurochem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","article-title":"Altered arginine metabolism in Alzheimer's disease brains","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1096\/fj.201700094R","article-title":"Argininosuccinate synthetase 1 contributes to gastric cancer invasion and progression by modulating autophagy","volume":"32","author":"Tsai","year":"2018","journal-title":"FASEB J"},{"key":"B46","first-page":"8","article-title":"Argininosuccinate synthase: at the center of arginine metabolism","volume":"2","author":"Haines","year":"2011","journal-title":"Int J Biochem Mol Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1172\/JCI60560","article-title":"Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12","volume":"122","author":"Montenegro","year":"2012","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12017-013-8271-9","article-title":"The role of reticulons in neurodegenerative diseases","volume":"16","author":"Chiurchi\u00f9","year":"2014","journal-title":"Neuromolecular Med"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T04:40:03Z","timestamp":1550810403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":48,"alternative-id":["10.3389\/fneur.2019.00131"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00131","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"article-number":"131"}}